2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 32.538 | 37.654 | 41.099 | 43.790 | 52.073 | 68.063 | 70.742 | 81.792 | 93.995 | 108.647 |
Total Income - EUR | 32.540 | 37.658 | 41.103 | 43.792 | 52.075 | 68.072 | 73.335 | 82.312 | 94.005 | 108.678 |
Total Expenses - EUR | 10.044 | 12.556 | 21.409 | 26.272 | 27.184 | 26.807 | 26.865 | 30.222 | 26.393 | 33.128 |
Gross Profit/Loss - EUR | 22.495 | 25.102 | 19.694 | 17.520 | 24.891 | 41.265 | 46.470 | 52.091 | 67.612 | 75.550 |
Net Profit/Loss - EUR | 21.519 | 23.972 | 19.283 | 17.082 | 24.371 | 40.584 | 45.763 | 51.273 | 66.691 | 74.580 |
Employees | 2 | 3 | 4 | 0 | 0 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Satya Medisan Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 2.050 | 1.480 | 9.253 | 7.745 | 6.292 | 11.392 | 10.665 | 7.717 | 4.468 | 1.307 |
Current Assets | 20.348 | 23.553 | 27.327 | 16.950 | 19.741 | 31.023 | 36.440 | 44.616 | 63.653 | 74.358 |
Inventories | 170 | 0 | 0 | 241 | 197 | 480 | 0 | 216 | 0 | 0 |
Receivables | 2.591 | 2.721 | 3.333 | 4.196 | 5.206 | 6.738 | 6.858 | 9.002 | 8.713 | 8.352 |
Cash | 17.587 | 20.832 | 23.993 | 12.513 | 14.339 | 23.804 | 29.582 | 35.397 | 54.940 | 66.007 |
Shareholders Funds | 21.631 | 24.085 | 19.394 | 17.192 | 24.478 | 40.690 | 45.866 | 51.374 | 66.792 | 74.681 |
Social Capital | 112 | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 |
Debts | 768 | 948 | 17.185 | 7.503 | 1.556 | 1.725 | 1.239 | 958 | 1.328 | 985 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Satya Medisan Srl